Cash on Hand for West Pharmaceutical Services (WST)
According to West Pharmaceutical Services's latest reported financial statements, the company's latest reported cash and short-term investments is $521.40M USD. Cash on hand here is cash, cash equivalents, and short-term investments reported at the end of each period — the most liquid assets on the balance sheet. Compare with total debt for a net cash/debt picture and with total assets for the share of assets held in cash.
Headline figure above is from the reporting period ending (reported ). Chart and table below cover the full reported history back to .
Currently viewingCash on HandSwitch metric
Latest period
$521.40M
YoY change
+63.3%
5Y CAGR
+5.2%
Peak year (2022)
$894.30M
Latest annual
$791.30M
Cash on Hand history chart for West Pharmaceutical Services (WST) from 1985 to 2025
Cash on Hand history table for West Pharmaceutical Services (WST) from 1985 to 2025
| Fiscal year | Period ended | Reported | Cash on Hand | YoY |
|---|---|---|---|---|
| 2025 | $791.30M | +63.3% | ||
| 2024 | $484.60M | -43.2% | ||
| 2023 | $853.90M | -4.5% | ||
| 2022 | $894.30M | +17.3% | ||
| 2021 | $762.60M | +23.9% | ||
| 2020 | $615.50M | +40.2% | ||
| 2019 | $439.10M | +30.1% | ||
| 2018 | $337.40M | +43.0% | ||
| 2017 | $235.90M | +16.2% | ||
| 2016 | $203.00M | -26.1% | ||
| 2015 | $274.60M | +7.6% | ||
| 2014 | $255.30M | +7.5% | ||
| 2013 | $237.50M | +36.3% | ||
| 2012 | $174.30M | +89.9% | ||
| 2011 | $91.80M | -16.7% | ||
| 2010 | $110.20M | +32.6% | ||
| 2009 | $83.10M | -9.2% | ||
| 2008 | $91.50M | -29.3% | ||
| 2007 | $129.40M | +174.7% | ||
| 2006 | $47.10M | -3.5% | ||
| 2005 | $48.80M | -29.1% | ||
| 2004 | $68.80M | +82.0% | ||
| 2003 | $37.80M | +13.9% | ||
| 2002 | $33.20M | -21.1% | ||
| 2001 | $42.10M | -1.4% | ||
| 2000 | $42.70M | -5.7% | ||
| 1999 | $45.30M | +44.7% | ||
| 1998 | $31.30M | -40.2% | ||
| 1997 | $52.30M | +90.9% | ||
| 1996 | $27.40M | +57.5% | ||
| 1995 | $17.40M | -36.0% | ||
| 1994 | $27.20M | +423.1% | ||
| 1993 | $5.20M | +73.3% | ||
| 1992 | $3.00M | +11.1% | ||
| 1991 | $2.70M | +22.7% | ||
| 1990 | $2.20M | +37.5% | ||
| 1989 | $1.60M | -68.6% | ||
| 1988 | $5.10M | -59.8% | ||
| 1987 | $12.70M | +71.6% | ||
| 1986 | $7.40M | -12.9% | ||
| 1985 | $8.50M | — |
Cash on Hand values are taken from West Pharmaceutical Services's reported balance sheets (10-Q quarterly and 10-K annual filings with the U.S. Securities and Exchange Commission). Each row shows the period end date and the date the filing was reported; YoY compares each figure to the same period one year earlier. Amounts are in USD as filed.
Analysis
West Pharmaceutical Services (WST) most recent annual cash and short-term investments stands at $791.30M (2025) – surged 63.3% year-over-year.
West Pharmaceutical Services cash and short-term investments compound annual growth for the 2020–2025 (5 years) window is +5.2%, with the latest reading among the more recent periods of the dataset.
West Pharmaceutical Services cash and short-term investments declined from $894.30M in 2022 to $791.30M in 2025, a 11.5% drawdown.
$894.30M stands as the all-time-high annual cash and short-term investments, posted in 2022, against a low of $1.60M during 1989.
Within Healthcare, West Pharmaceutical Services (WST) ranks 9th among 8 peers we track. The peer median for cash and short-term investments is $11.85B.
West Pharmaceutical Services Cash on Hand by Year
West Pharmaceutical Services Cash on Hand 2025: $791.30M
West Pharmaceutical Services cash and short-term investments in 2025 was $791.30M, surged 63.3% from 2024.
West Pharmaceutical Services Cash on Hand 2024: $484.60M
West Pharmaceutical Services cash and short-term investments in 2024 was $484.60M, plunged 43.2% below 2023.
West Pharmaceutical Services Cash on Hand 2023: $853.90M
West Pharmaceutical Services cash and short-term investments in 2023 was $853.90M, edged down 4.5% below 2022.
West Pharmaceutical Services Cash on Hand 2022: $894.30M
West Pharmaceutical Services cash and short-term investments in 2022 was $894.30M, grew 17.3% from 2021. This figure represents the highest annual value in the available history.
West Pharmaceutical Services Cash on Hand 2021: $762.60M
West Pharmaceutical Services cash and short-term investments in 2021 was $762.60M.
See more financial history for West Pharmaceutical Services (WST).
Sector peers — Cash on Hand
Companies in the same sector as West Pharmaceutical Services, ranked by their latest cash and short-term investments.
| Company | Cash on Hand | Sector |
|---|---|---|
| UnitedHealth Group Incorporated (UNH) | $28.12B | Healthcare |
| Novo Nordisk A/S (NVO) | $26.96B | Healthcare |
| Johnson & Johnson (JNJ) | $20.10B | Healthcare |
| Merck & Co., Inc. (MRK) | $14.56B | Healthcare |
| Amgen Inc. (AMGN) | $9.13B | Healthcare |
| Eli Lilly and Company (LLY) | $7.27B | Healthcare |
| AstraZeneca PLC (AZN) | $5.74B | Healthcare |
| AbbVie Inc. (ABBV) | $5.26B | Healthcare |
Frequently asked questions
What is West Pharmaceutical Services's cash and short-term investments?
- Latest reported cash and short-term investments for West Pharmaceutical Services (WST) is $521.40M (period ending March 31, 2026).
How has West Pharmaceutical Services cash and short-term investments changed year-over-year?
- West Pharmaceutical Services (WST) cash and short-term investments changed +63.3% year-over-year on the latest annual filing.
What is the long-term growth rate of West Pharmaceutical Services cash and short-term investments?
- West Pharmaceutical Services (WST) cash and short-term investments compound annual growth rate is +5.2% over the most recent 5 years available.
When did West Pharmaceutical Services cash and short-term investments hit its highest annual value?
- West Pharmaceutical Services cash and short-term investments reached its highest annual value of $894.30M in 2022.
What was West Pharmaceutical Services cash and short-term investments in 2024?
- West Pharmaceutical Services (WST) cash and short-term investments in 2024 was $484.60M.
What was West Pharmaceutical Services cash and short-term investments in 2025?
- West Pharmaceutical Services (WST) cash and short-term investments in 2025 was $791.30M.
Metrics overview
Pick a metric for charts, filings, and peers — each row shows the latest TTM or annual value with year-over-year change.
Explore more
WST Overview
Company profile, financial tools, and key metrics
WST Revenue Counter
Earns $102.12 every second. See per minute, hour, and day.
WST Earnings Counter
Earns $17.21 per second net profit. See per minute, hour, and day.
WST Economic Scale
Exceeds Belize's GDP. Compare with world economies.
WST What If Invested
What if you had invested $1,000? See historical returns from any date.
WST How It Makes Money
Discover visual breakdown of $3.22B in revenue — where it comes from and where it goes.
WST Stock Seasonality
Best and worst months to invest. Historical monthly returns heatmap.
WST Price Target Scenarios
Model bear, base, and bull cases with EPS growth and exit P/E — pre-filled from analysts and history.
WST Daily Price Character
Steady · 44.8% historical win rate (green days). Streaks & record days.
WST Buybacks
1.65% TTM buyback yield. Shareholder yield & SBC comparison.
WST Stock Split History
4 splits on record. Dates, ratios, and cumulative multiple.
WST Dividend Profile
Yield: 0.29%. Safety: 6/8. See full history.
WST Dividend Calculator
How much dividend income would $1,000 have earned? Calculate from any date.
WST Dividend Forecast
Project future income with DRIP, growth assumptions, and optional monthly contributions.